(Total Views: 94)
Posted On: 02/18/2022 8:20:41 AM
Post# of 44009
$AVCO Avalon is leveraging its mRNA-based FLASH-CAR platform to develop autologous and universal CAR-NK technology and cellular therapies for the potential treatment of hematologic malignancies and solid tumors. https://finance.yahoo.com/news/avalon-globoca...21173.html
(0)
(0)
